NTLA Intellia Therapeutics shares rise 832 percent after narrower Q4 2025 loss beats analyst expectations GOSS Gossamer Bio shares rise 521 percent even as Q4 2025 EPS narrowly misses analyst expectations BSBR Santander BR reports sharp Q1 2023 EPS miss edges modestly higher as investors look past nearterm weakness Is Brixmor BRX stock appealing for longterm investors Q4 2025 Earnings Beat Estimates Is TFI TFII stock overvalued by the market TFI posts 263 EPS beat topping street estimates HPAIW Helport AI management prioritizes vertical AI solution launches to capture growing market demand The Williams Companies Inc WMB Positioned for Midstream Sector Tailwinds Amid Stable Industry Cash Flow Dynamics What share repurchase Autolus AUTL Autolus posts 252 wider EPS loss no revenue